✦ LIBER ✦

MP70-20 A PHASE 2 TRIAL OF PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATE (PSMA ADC) IN TAXANE-TREATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)

✍ Scribed by Petrylak, Daniel; Smith, David C.; Appleman, Leonard J.; Fleming, Mark; Hussain, Arif; Dreicer, Robert; Sartor, A. Oliver; Shore, Neil; Vogelzang, Nicholas J.; Youssoufian, Hagop; Olson, William; Stambler, Nancy; Huang, Kathleen; Israel, Robert

Book ID: 122151248
Publisher: Lippincott Williams and Wilkins
Year: 2014
Tongue: English
Weight: 311 KB
Volume: 191
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2014.02.2218

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

870 A phase 2 trial of prostate specific

870 A phase 2 trial of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-treated metastatic castration-resistant prostate cancer (MCRPC)

✍ Petrylak, D.; Smith, D.C.; Appleman, L.J.; Fleming, M.; Hussain, A.; Dreicer, R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 201 KB

244 Prostate Specific Membrane Antigen A

244 Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC): a Phase 1 Trial in Castration-Resistant Metastatic Prostate Cancer (mCRPC)

✍ Petrylak, D.; Kantoff, P.; Mega, A.; Stephenson, J.; Vogelzang, N.; Fleming, M.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABEL

PHASE 2a TRIAL OF 177LUTETIUM RADIOLABELED ANTI- PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) MONOCLONAL ANTIBODY J591 (177Lu-J591) IN PATIENTS (PTS) WITH METASTATIC ANDROGEN-INDEPENDENT PROSTATE CANCER (AIPC)

✍ Bander, Neil H; Nanus, David M; Tagawa, Scott; Vallabhajosula, Shankar; Goldsmit 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 125 KB